| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | cone cell pedicle | 1.40e-04 | 5 | 79 | 2 | GO:0044316 | |
| Domain | IMPORTIN_B_NT | 1.56e-03 | 14 | 79 | 2 | PS50166 | |
| Domain | IBN_N | 1.79e-03 | 15 | 79 | 2 | PF03810 | |
| Domain | IBN_N | 2.04e-03 | 16 | 79 | 2 | SM00913 | |
| Domain | Importin-beta_N | 2.31e-03 | 17 | 79 | 2 | IPR001494 | |
| Domain | DEP | 3.86e-03 | 22 | 79 | 2 | PF00610 | |
| Domain | DEP | 3.86e-03 | 22 | 79 | 2 | PS50186 | |
| Domain | DEP | 3.86e-03 | 22 | 79 | 2 | SM00049 | |
| Domain | DEP_dom | 4.22e-03 | 23 | 79 | 2 | IPR000591 | |
| Domain | Spectrin | 4.22e-03 | 23 | 79 | 2 | PF00435 | |
| Pubmed | FAM171A1 IQSEC3 SORBS2 DST AP2A2 EHMT2 KTN1 KSR2 YLPM1 RAPGEF4 AAK1 LRRC7 EMSY | 2.53e-07 | 963 | 79 | 13 | 28671696 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | THOC1 EPC2 SP2 DST EHMT2 CTR9 BRD4 KTN1 YLPM1 TMEM209 CLOCK CPSF3 EMSY SCAF4 | 1.18e-06 | 1294 | 79 | 14 | 30804502 |
| Pubmed | 2.69e-06 | 268 | 79 | 7 | 33640491 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 3.52e-06 | 398 | 79 | 8 | 35016035 | |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 3.68e-06 | 281 | 79 | 7 | 28706196 | |
| Pubmed | 3.77e-06 | 282 | 79 | 7 | 23667531 | ||
| Pubmed | 4.03e-06 | 14 | 79 | 3 | 16452088 | ||
| Pubmed | Exome sequencing identifies KIAA1377 and C5orf42 as susceptibility genes for monomelic amyotrophy. | 5.09e-06 | 2 | 79 | 2 | 22264561 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 19279235 | ||
| Pubmed | TET2 SOX9 SORBS2 HIVEP2 DST EHMT2 CTR9 YLPM1 RAPGEF4 DEF8 DHX35 ZNF619 HERPUD2 | 6.16e-06 | 1285 | 79 | 13 | 35914814 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 1.02e-05 | 774 | 79 | 10 | 15302935 | |
| Pubmed | Pluripotency transcription factors and Tet1/2 maintain Brd4-independent stem cell identity. | 1.53e-05 | 3 | 79 | 2 | 29662175 | |
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 28073847 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 1.56e-05 | 351 | 79 | 7 | 38297188 | |
| Pubmed | 1.76e-05 | 497 | 79 | 8 | 23414517 | ||
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | 1.79e-05 | 498 | 79 | 8 | 36634849 | |
| Pubmed | 1.84e-05 | 360 | 79 | 7 | 33111431 | ||
| Pubmed | FAM171A1 ACOT8 IPO7 CTR9 SBF2 YLPM1 NAGLU BCKDHA CPSF3 ZYX TULP3 | 2.48e-05 | 1049 | 79 | 11 | 27880917 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 2.53e-05 | 861 | 79 | 10 | 36931259 | |
| Pubmed | 3.05e-05 | 4 | 79 | 2 | 16704975 | ||
| Pubmed | 3.05e-05 | 4 | 79 | 2 | 33134768 | ||
| Pubmed | 3.05e-05 | 4 | 79 | 2 | 24248598 | ||
| Pubmed | 4.74e-05 | 418 | 79 | 7 | 34709266 | ||
| Pubmed | 5.07e-05 | 5 | 79 | 2 | 12401793 | ||
| Pubmed | Recognition Elements in the Histone H3 and H4 Tails for Seven Different Importins. | 5.07e-05 | 5 | 79 | 2 | 27528606 | |
| Pubmed | SPOP mutation induces DNA methylation via stabilizing GLP/G9a. | 5.07e-05 | 5 | 79 | 2 | 34588438 | |
| Pubmed | Multiple pathways contribute to nuclear import of core histones. | 5.07e-05 | 5 | 79 | 2 | 11493596 | |
| Pubmed | 6.00e-05 | 591 | 79 | 8 | 15231748 | ||
| Pubmed | Numb expression and asymmetric versus symmetric cell division in distal embryonic lung epithelium. | 7.60e-05 | 6 | 79 | 2 | 22713487 | |
| Pubmed | 7.69e-05 | 191 | 79 | 5 | 31177093 | ||
| Pubmed | 9.91e-05 | 1014 | 79 | 10 | 32416067 | ||
| Pubmed | 1.06e-04 | 7 | 79 | 2 | 11682607 | ||
| Pubmed | 1.06e-04 | 7 | 79 | 2 | 22727665 | ||
| Pubmed | 1.06e-04 | 7 | 79 | 2 | 29774127 | ||
| Pubmed | SOCS2 Binds to and Regulates EphA2 through Multiple Mechanisms. | 1.19e-04 | 110 | 79 | 4 | 28883622 | |
| Pubmed | 1.20e-04 | 653 | 79 | 8 | 33742100 | ||
| Pubmed | 1.29e-04 | 660 | 79 | 8 | 32780723 | ||
| Pubmed | 1.40e-04 | 44 | 79 | 3 | 27505670 | ||
| Pubmed | 1.41e-04 | 8 | 79 | 2 | 27114554 | ||
| Pubmed | 1.41e-04 | 8 | 79 | 2 | 9687515 | ||
| Pubmed | Transportin 1 is a major nuclear import receptor of the nitric oxide synthase interacting protein. | 1.41e-04 | 8 | 79 | 2 | 36690276 | |
| Pubmed | 1.67e-04 | 686 | 79 | 8 | 29987050 | ||
| Pubmed | The histone H3K9 methyltransferase G9a regulates tendon formation during development. | 1.82e-04 | 9 | 79 | 2 | 39237663 | |
| Pubmed | 1.82e-04 | 9 | 79 | 2 | 32344102 | ||
| Pubmed | Identification of two novel RanGTP-binding proteins belonging to the importin beta superfamily. | 1.82e-04 | 9 | 79 | 2 | 11024021 | |
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 1.82e-04 | 123 | 79 | 4 | 26912792 | |
| Pubmed | 1.93e-04 | 49 | 79 | 3 | 18936436 | ||
| Pubmed | 2.25e-04 | 130 | 79 | 4 | 12421765 | ||
| Pubmed | Exportin 4: a mediator of a novel nuclear export pathway in higher eukaryotes. | 2.27e-04 | 10 | 79 | 2 | 10944119 | |
| Pubmed | Development of migrating tendon-bone attachments involves replacement of progenitor populations. | 2.27e-04 | 10 | 79 | 2 | 30504126 | |
| Pubmed | 2.55e-04 | 549 | 79 | 7 | 38280479 | ||
| Pubmed | 2.57e-04 | 54 | 79 | 3 | 25496667 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 2.68e-04 | 934 | 79 | 9 | 33916271 | |
| Pubmed | 2.72e-04 | 55 | 79 | 3 | 18570454 | ||
| Pubmed | 2.76e-04 | 11 | 79 | 2 | 22509482 | ||
| Pubmed | Meta-analysis of genome-wide association data of bipolar disorder and major depressive disorder. | 2.76e-04 | 11 | 79 | 2 | 20351715 | |
| Pubmed | Mitochondrial phosphoproteome revealed by an improved IMAC method and MS/MS/MS. | 3.02e-04 | 57 | 79 | 3 | 17208939 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | 3.04e-04 | 565 | 79 | 7 | 25468996 | |
| Pubmed | A shared transcriptional code orchestrates temporal patterning of the central nervous system. | 3.31e-04 | 12 | 79 | 2 | 34767545 | |
| Pubmed | Reciprocal Negative Regulation Between Lmx1a and Lmo4 Is Required for Inner Ear Formation. | 3.31e-04 | 12 | 79 | 2 | 29769265 | |
| Pubmed | 3.31e-04 | 12 | 79 | 2 | 28949961 | ||
| Pubmed | Nucleophosmin deposition during mRNA 3' end processing influences poly(A) tail length. | 3.31e-04 | 12 | 79 | 2 | 21822216 | |
| Pubmed | 3.77e-04 | 1429 | 79 | 11 | 35140242 | ||
| Pubmed | 3.91e-04 | 13 | 79 | 2 | 15634692 | ||
| Pubmed | WW domains provide a platform for the assembly of multiprotein networks. | 4.29e-04 | 154 | 79 | 4 | 16055720 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 4.48e-04 | 430 | 79 | 6 | 35044719 | |
| Pubmed | The tumor suppressor Cdc73 functionally associates with CPSF and CstF 3' mRNA processing factors. | 4.55e-04 | 14 | 79 | 2 | 19136632 | |
| Pubmed | Novel DNA sequence variations of cytochrome P450 genes in the Han Chinese population. | 4.55e-04 | 14 | 79 | 2 | 19290787 | |
| Pubmed | 4.55e-04 | 14 | 79 | 2 | 15836771 | ||
| Pubmed | Identification of the human testis protein phosphatase 1 interactome. | 5.08e-04 | 68 | 79 | 3 | 21382349 | |
| Pubmed | TET2 catalyzes active DNA demethylation of the Sry promoter and enhances its expression. | 5.25e-04 | 15 | 79 | 2 | 31530896 | |
| Pubmed | EHMT2 directs DNA methylation for efficient gene silencing in mouse embryos. | 5.25e-04 | 15 | 79 | 2 | 26576615 | |
| Pubmed | 5.62e-04 | 449 | 79 | 6 | 31732153 | ||
| Pubmed | 5.99e-04 | 16 | 79 | 2 | 15384171 | ||
| Pubmed | 5.99e-04 | 16 | 79 | 2 | 10580128 | ||
| Pubmed | 6.78e-04 | 17 | 79 | 2 | 18452912 | ||
| Pubmed | Notum attenuates Wnt/β-catenin signaling to promote tracheal cartilage patterning. | 7.61e-04 | 18 | 79 | 2 | 29428562 | |
| Pubmed | 7.61e-04 | 18 | 79 | 2 | 23637336 | ||
| Pubmed | 7.61e-04 | 18 | 79 | 2 | 27352137 | ||
| Pubmed | Overexpression of Smurf2 stimulates endochondral ossification through upregulation of beta-catenin. | 7.61e-04 | 18 | 79 | 2 | 18052755 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | 7.73e-04 | 1082 | 79 | 9 | 38697112 | |
| Pubmed | 8.48e-04 | 486 | 79 | 6 | 20936779 | ||
| Pubmed | 8.50e-04 | 19 | 79 | 2 | 24165912 | ||
| Pubmed | 8.50e-04 | 19 | 79 | 2 | 12721789 | ||
| Pubmed | 9.13e-04 | 493 | 79 | 6 | 15368895 | ||
| Pubmed | Local retinoic acid signaling directs emergence of the extraocular muscle functional unit. | 9.43e-04 | 20 | 79 | 2 | 33201874 | |
| Pubmed | 9.43e-04 | 20 | 79 | 2 | 21689717 | ||
| Pubmed | Essential roles of G9a in cell proliferation and differentiation during tooth development. | 9.43e-04 | 20 | 79 | 2 | 28527696 | |
| Pubmed | 9.60e-04 | 331 | 79 | 5 | 29199018 | ||
| Pubmed | Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins. | 9.72e-04 | 499 | 79 | 6 | 22810586 | |
| Pubmed | Isolation of differentially expressed genes from wild-type and Twist mutant mouse limb buds. | 1.04e-03 | 21 | 79 | 2 | 12124942 | |
| Pubmed | Candidate genes and cerebral palsy: a population-based study. | 1.04e-03 | 21 | 79 | 2 | 18977990 | |
| Pubmed | 1.04e-03 | 21 | 79 | 2 | 27365293 | ||
| Pubmed | 1.04e-03 | 506 | 79 | 6 | 30890647 | ||
| Pubmed | 1.14e-03 | 22 | 79 | 2 | 12812986 | ||
| Pubmed | 1.14e-03 | 22 | 79 | 2 | 23266558 | ||
| Pubmed | 1.14e-03 | 22 | 79 | 2 | 27527664 | ||
| Pubmed | 1.15e-03 | 708 | 79 | 7 | 39231216 | ||
| Pubmed | 1.16e-03 | 709 | 79 | 7 | 22988430 | ||
| Pubmed | ADAM10 hyperactivation acts on piccolo to deplete synaptic vesicle stores in Huntington's disease. | 1.18e-03 | 202 | 79 | 4 | 33601422 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_GHRL_POS_NE_PRECURSOR_CELL | 5.80e-06 | 429 | 79 | 9 | M45694 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | THOC1 TET2 SOX9 EPC2 FCHSD2 ACOT8 IPO7 CTR9 BRD4 YLPM1 DEPDC1 CEP126 CD180 CPLANE1 KIF24 PCDH18 EMSY | 2.77e-06 | 1252 | 79 | 17 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.37e-08 | 198 | 79 | 7 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 6.83e-08 | 200 | 79 | 7 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.35e-06 | 196 | 79 | 6 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.43e-06 | 198 | 79 | 6 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 1.48e-06 | 199 | 79 | 6 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.52e-06 | 200 | 79 | 6 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | control-Myeloid-pDC|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.23e-05 | 168 | 79 | 5 | affc39c7568b7df4b36af6f5b0e3702a18b6268c | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.91e-05 | 184 | 79 | 5 | 9cbfb9f09476b4d09eb8f92c6f21e449dabcfa98 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.91e-05 | 184 | 79 | 5 | d48807f9da48bdd015a54c606d2e2a311f181396 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma-chondrocyte|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.12e-05 | 188 | 79 | 5 | c9270517e6940e9793586f67f02431210552f278 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 2.40e-05 | 193 | 79 | 5 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | background-Cholangiocytes|background / Sample and Cell Type and Tumor Cluster (all cells) | 2.40e-05 | 193 | 79 | 5 | 9152241073dbe02ac2c11d86bec9b5b529196f6e | |
| ToppCell | LPS-IL1RA-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.46e-05 | 194 | 79 | 5 | 43f92b0533e26633dc94cce554045d641ef8fd76 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.46e-05 | 194 | 79 | 5 | 1d39d968730a7e85b6161c1c8a6bd38afe9bcad7 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.72e-05 | 198 | 79 | 5 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | distal-Epithelial-Club-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.72e-05 | 198 | 79 | 5 | 77c7fa7626ea35cb50de9c2f2df637d22e77d3fe | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.72e-05 | 198 | 79 | 5 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_secretory|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.78e-05 | 199 | 79 | 5 | a8bfc0b93ad9968cf52a25be86995ffe436bd636 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.85e-05 | 200 | 79 | 5 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.85e-05 | 200 | 79 | 5 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 2.85e-05 | 200 | 79 | 5 | 3b97920e1e6e2f09ddba2a861baa9c00c2970f4c | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.85e-05 | 200 | 79 | 5 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | LPS_anti-TNF-Endothelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.85e-05 | 200 | 79 | 5 | 1d105eeda5a2c51f9a4654ffc79b7e2348ad593b | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.85e-05 | 200 | 79 | 5 | b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.85e-05 | 200 | 79 | 5 | 60d2cbf41f37f1b11eddb4c9d9246c9c1fc5a5af | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligodendroglioma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 9.78e-05 | 135 | 79 | 4 | b128596653a5e3b64ed7f657bbfeda35438e2e48 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-pDCs|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 1.79e-04 | 158 | 79 | 4 | 2af7beb48272e5368d9ba6b80f08d47ab8556c08 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-plasma_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-04 | 160 | 79 | 4 | 0544bc465af208da448858d6e174ff56f2e08a46 | |
| ToppCell | B_cells-ABCs|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 2.07e-04 | 164 | 79 | 4 | f45013706a917f0f0d69c23f288128f252cd60c7 | |
| ToppCell | NS-control-d_0-4-Myeloid-pDC|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.12e-04 | 165 | 79 | 4 | 8b2d43d7c4ee07bd999bd51bc15117ce1fbb2d86 | |
| ToppCell | control-Myeloid-pDC|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.12e-04 | 165 | 79 | 4 | 243c74adf8d993ff92acbff2768bdc5a1693eca3 | |
| ToppCell | 3'-Adult-LargeIntestine-Epithelial-mature_enterocytic-Paneth|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.16e-04 | 166 | 79 | 4 | b64ab3d13b76bba3c305ebbfc96f983cd6ca30c9 | |
| ToppCell | droplet-Marrow-nan-24m-Lymphocytic-plasma_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-04 | 166 | 79 | 4 | b3d9b61847c6c96b8cb28b8a6aeda52f43c706ab | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_vein-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.21e-04 | 167 | 79 | 4 | d7fe24cdc4b55a9555ce9e20699f5036b88148e9 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-T_cells-TRGV2_gdT|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.27e-04 | 168 | 79 | 4 | 2765d98f0b7f6861d662937535e051d41dba3500 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-04 | 169 | 79 | 4 | 5f5bec13208f4c3b6eacbba180c8a6402743b76e | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.32e-04 | 169 | 79 | 4 | 8f397cf4f9fd7c6fa88d01a95289ce2a6bc6938d | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-04 | 169 | 79 | 4 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-D_cells_(SST+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.42e-04 | 171 | 79 | 4 | fa5cc720bd0045d0307439be547b41d56def5b43 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.53e-04 | 173 | 79 | 4 | 869da6a65d1b9b7529c666ec44e3c8ddec2ea408 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.53e-04 | 173 | 79 | 4 | 0672bd8a4a9d18af343d01f09253fb3388896c10 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.53e-04 | 173 | 79 | 4 | 870e091ec30be01a900e1cb8b9ef1880e3b7b50d | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.53e-04 | 173 | 79 | 4 | b799c06a6a5754668e789f70c0c8bc1508568575 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.65e-04 | 175 | 79 | 4 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.65e-04 | 175 | 79 | 4 | 1ea6cf9da26601646f57fa14d558a5e9e1f0b345 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Proximal_secretory_3|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.70e-04 | 176 | 79 | 4 | 8d9d0fb46c418b2067be58aec822e8c2b1561461 | |
| ToppCell | Healthy_Control-Lymphoid-T-Treg|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 2.70e-04 | 176 | 79 | 4 | 7765a5b04ac117d525201f8eb08e1754e55942ff | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.70e-04 | 176 | 79 | 4 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | AT1-AT2_cells-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 2.70e-04 | 176 | 79 | 4 | f86832cfeff5b3cfffe4455c1b96a1420d48ba1e | |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial-goblet-Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.76e-04 | 177 | 79 | 4 | e1e45956887371b1c18f1eb479dd930031497520 | |
| ToppCell | (06)_Krt4/13+|World / shred by cell type and Timepoint | 2.82e-04 | 178 | 79 | 4 | 46efdf03aa1317bc600138e871509b995e773cce | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.82e-04 | 178 | 79 | 4 | fcbbcc44271515de1969b4732b6441c012693d5f | |
| ToppCell | Club_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 2.82e-04 | 178 | 79 | 4 | be64d4be23fb96a4cdd7980c58880fdfe817747f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.82e-04 | 178 | 79 | 4 | 31c847d7f7aa0f6d820afbb45d507992f5e9dc2f | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-epithelial_progenitor_cell-CLDN10+_cells|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.88e-04 | 179 | 79 | 4 | 7eca1e19ae6b5b1f18c721691dc3e860705628f2 | |
| ToppCell | AT1_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 2.88e-04 | 179 | 79 | 4 | 1603117b52623663458a977c94bf7f9f6c1114b8 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_vein-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.95e-04 | 180 | 79 | 4 | 27e8bbee388e64dd79d70b160b76d45b1f398006 | |
| ToppCell | ASK454-Epithelial|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.07e-04 | 182 | 79 | 4 | ab15316cff989b61ff397a866d7ca8b49c13e981 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.07e-04 | 182 | 79 | 4 | 818b5155ec81f0059048d6070a108116ecd72e3c | |
| ToppCell | 3'_v3-bone_marrow-Myeloid_Dendritic-DC2|bone_marrow / Manually curated celltypes from each tissue | 3.14e-04 | 183 | 79 | 4 | f482e4fe011fa450a475034b1e25587233855bdb | |
| ToppCell | Control-Endothelial_cells-Pulmonary_venous_endothelial_cells|Control / group, cell type (main and fine annotations) | 3.14e-04 | 183 | 79 | 4 | 46be9f96755c7b65aeac061d95d15abeb6466034 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.14e-04 | 183 | 79 | 4 | fc9a7ba148c22d0c8a46f6bc56c772929ac496f7 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.20e-04 | 184 | 79 | 4 | ca940a4f4970285ed284d5517d142abab0682044 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 3.20e-04 | 184 | 79 | 4 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D175|Adult / Lineage, Cell type, age group and donor | 3.27e-04 | 185 | 79 | 4 | 32b4e68e551d435a732f253f6ad83408c759a642 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.27e-04 | 185 | 79 | 4 | 7925519b855f76444a0b57382ce35d89457b0b14 | |
| ToppCell | droplet-Liver-LIVER-30m-Lymphocytic|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.34e-04 | 186 | 79 | 4 | ad55da1dbb173721101126826b6db9d3434cb377 | |
| ToppCell | Substantia_nigra-Neuronal|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 3.34e-04 | 186 | 79 | 4 | 3f889083fcffe516388e9b03a5e23af2010ced33 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.34e-04 | 186 | 79 | 4 | 5302399825f213d105ac70b91366a4513b732838 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_vein|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.40e-04 | 187 | 79 | 4 | e35716f8b482be3bf5ab79f087a9caf67a9d197a | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.40e-04 | 187 | 79 | 4 | f3397dbc23b6c2f24e2c1ba887d8f9aef3ee01a1 | |
| ToppCell | COVID-19-Endothelial_cells-Pulmonary_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 3.40e-04 | 187 | 79 | 4 | 2d20193a6cacdfa4877457c97b0077408942186c | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.40e-04 | 187 | 79 | 4 | f5a202d5f8eb57b57d80815ce98774e04c387383 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Alv_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.47e-04 | 188 | 79 | 4 | 73f6ec915934154f435a376cb274b058ff7c5f35 | |
| ToppCell | droplet-Spleen-nan-3m-Lymphocytic-B_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.47e-04 | 188 | 79 | 4 | 8b1485e63cd4020ba5334a8d4b84725b164549bf | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.47e-04 | 188 | 79 | 4 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.54e-04 | 189 | 79 | 4 | c392491aabe8a3e90974ab2ea123bbbe5200439d | |
| ToppCell | COVID-19-Heart-Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.54e-04 | 189 | 79 | 4 | 2586f4088721c5debec86c2b211b739fd33713eb | |
| ToppCell | Fibroblasts-CD55+_Fibroblasts|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 3.62e-04 | 190 | 79 | 4 | b4088128f5acf53f43244c9af9fe44e033f1a57a | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.62e-04 | 190 | 79 | 4 | 474cbbab8f3b0a6881fa6c92edb78e43999f9ab0 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_DC-DC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.62e-04 | 190 | 79 | 4 | d06800ec9f6065c1cc536ed99e8569732272a94f | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_DC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.62e-04 | 190 | 79 | 4 | 485073e831afebdb393c7f4b622504d43d1b778b | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 3.69e-04 | 191 | 79 | 4 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_B|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.69e-04 | 191 | 79 | 4 | 8dda37ebf74b587129795f61541cc511ec97a314 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.69e-04 | 191 | 79 | 4 | 23776c7302cead3881b39127398f3b3e0d27885e | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.69e-04 | 191 | 79 | 4 | a7b18bcf27c38ad2353c239ecb309c80f3ef3359 | |
| ToppCell | Control-Endothelial-VE_Venous|Control / Disease state, Lineage and Cell class | 3.69e-04 | 191 | 79 | 4 | 617546cf4883dedf3323e03a53ba5adec334cf8e | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 3.69e-04 | 191 | 79 | 4 | 2b427741a58921e161101a282d1fe526cd9e760d | |
| ToppCell | 3'-Broncho-tracheal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_acinar_cell-SMG_duct|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.76e-04 | 192 | 79 | 4 | c227ab1914191e839fc39c9adc2080026d4b04fc | |
| ToppCell | 3'-Broncho-tracheal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_acinar_cell-SMG_duct-SMG_duct_L.0.6.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.76e-04 | 192 | 79 | 4 | bf187a57a559ab732bb815892af45ca922966ac6 | |
| ToppCell | 3'-Broncho-tracheal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_acinar_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.76e-04 | 192 | 79 | 4 | f573b2d205bd4d053a548af3fe3ff9de7be0cd2b | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.76e-04 | 192 | 79 | 4 | c618ede75dce3988c87a5b8f98d8e94e1dd66efd | |
| ToppCell | B_cells-Memory_B_cells|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 3.76e-04 | 192 | 79 | 4 | eef591095921ede098f41a2b81897b18915bb753 | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_DC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.84e-04 | 193 | 79 | 4 | c6633aca0eb4d699c4d3da3199b84bebd87e2d31 | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular-Goblet|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.84e-04 | 193 | 79 | 4 | 71bf8fb5314b79cb30f4eb9c8459b21f10cd6d35 | |
| ToppCell | droplet-Fat-Mat-18m-Endothelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.84e-04 | 193 | 79 | 4 | 54024a373e42e1c0bcc327dc084564b83b63a9d4 | |
| ToppCell | droplet-Fat-Mat-18m-Endothelial-endothelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.84e-04 | 193 | 79 | 4 | 81d908594d2983ba7e7c1ec25afdde4315d9690e | |
| ToppCell | Control-Endothelial-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.84e-04 | 193 | 79 | 4 | aff0649c73c634bc6ff0dc7759b4693a9236bf05 | |
| ToppCell | Control-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.84e-04 | 193 | 79 | 4 | c5f9fe03e64c211d4bcd4959e5b32f14841e336a | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular-Goblet-Goblet|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.84e-04 | 193 | 79 | 4 | b05e110b13d35d34294357c8e1c4fd23bf4b6c92 | |
| Disease | Amyotrophy, monomelic | 6.90e-06 | 2 | 78 | 2 | C1865384 | |
| Disease | systolic blood pressure, response to cold pressor test | 4.12e-05 | 4 | 78 | 2 | EFO_0005404, EFO_0006335 | |
| Disease | hepatitis (biomarker_via_orthology) | 4.12e-05 | 4 | 78 | 2 | DOID:2237 (biomarker_via_orthology) | |
| Disease | pulmonary hypertension (is_implicated_in) | 6.85e-05 | 30 | 78 | 3 | DOID:6432 (is_implicated_in) | |
| Disease | idiopathic pulmonary fibrosis (is_implicated_in) | 2.45e-04 | 9 | 78 | 2 | DOID:0050156 (is_implicated_in) | |
| Disease | melanoma | 3.54e-04 | 126 | 78 | 4 | EFO_0000756 | |
| Disease | chronic obstructive pulmonary disease | 4.68e-04 | 688 | 78 | 8 | EFO_0000341 | |
| Disease | bronchiolitis obliterans (is_marker_for) | 5.28e-04 | 13 | 78 | 2 | DOID:2799 (is_marker_for) | |
| Disease | chemokine (C-C motif) ligand 27 measurement | 8.56e-04 | 70 | 78 | 3 | EFO_0008082 | |
| Disease | response to bronchodilator, FEV/FEC ratio | 9.41e-04 | 766 | 78 | 8 | EFO_0004713, GO_0097366 | |
| Disease | syndrome (implicated_via_orthology) | 1.03e-03 | 18 | 78 | 2 | DOID:225 (implicated_via_orthology) | |
| Disease | trauma exposure measurement | 1.14e-03 | 172 | 78 | 4 | EFO_0010703 | |
| Disease | smoking status measurement, chronic obstructive pulmonary disease | 1.66e-03 | 88 | 78 | 3 | EFO_0000341, EFO_0006527 | |
| Disease | ulcerative colitis | 1.96e-03 | 335 | 78 | 5 | EFO_0000729 | |
| Disease | colon adenocarcinoma (is_marker_for) | 1.99e-03 | 25 | 78 | 2 | DOID:234 (is_marker_for) | |
| Disease | Acute kidney injury | 1.99e-03 | 25 | 78 | 2 | HP_0001919 | |
| Disease | cerebellum cortex volume change measurement, age at assessment | 2.15e-03 | 26 | 78 | 2 | EFO_0008007, EFO_0021497 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VVRQTPTQHFKNQFP | 101 | O95150 | |
| ASFQQAQPSPMQHQF | 126 | O14734 | |
| QPKQFIHIQPFNLDN | 96 | Q52LR7 | |
| HNEPNPQRFTKIQNT | 316 | O60909 | |
| SNPQDFNPQHFLNEK | 406 | P11509 | |
| QININNPFVFKHISN | 296 | Q9UKF6 | |
| QPFDPHFKINNAVSN | 176 | P51589 | |
| EQPEIQVAHFPFKNN | 281 | P08697 | |
| QTQQFQAVHPATQKP | 496 | Q2M2I8 | |
| FQSLTHQSPPQQNVQ | 1076 | O60885 | |
| AHNIKEQEPTQQFIP | 76 | P10144 | |
| PFTPNHQQHNNFFTL | 11 | Q6PIY7 | |
| PNFQSDQQSKRTPLH | 676 | Q96KQ7 | |
| QSSPNLGHIINQKQF | 196 | P48448 | |
| APQSPFQNLHFLQVL | 436 | Q99467 | |
| NSEHFNQNEPKVLFN | 1451 | Q96F81 | |
| VAQGIPFQQHQFDKN | 686 | P54802 | |
| NPQQEVQNIFKAKHP | 846 | O94973 | |
| STHFQLQNQPPQKEF | 321 | Q8NFJ5 | |
| FTVQINDINDNPPHF | 451 | Q9HCL0 | |
| YHNLSKQQNESPQPL | 46 | P35228 | |
| SLQQNYPPVQEHQQK | 761 | Q5VUB5 | |
| QLFKNENPNPHMAFQ | 461 | Q86WG5 | |
| PFQHNPEYVQQASKN | 1051 | Q96NW7 | |
| SEHFPQPTQQIKNIV | 2566 | Q9UKN7 | |
| FPFPQITNNEELNQK | 2881 | Q03001 | |
| EKQHPQQPQVITSYN | 71 | Q8NBH2 | |
| LHPSPQCTRQQKNFN | 546 | Q6VAB6 | |
| HQEPVNESFQKSRQP | 946 | Q5CZC0 | |
| HQQVSPYQTQPTFQA | 3916 | Q9Y6V0 | |
| FPNNVEPVTNHFITQ | 806 | O95373 | |
| TFPQHVLSQPQQVRK | 776 | Q9ULH7 | |
| FHQSFPNIEGQNNKL | 441 | Q5TB30 | |
| NHQNPQNKTSPFSVS | 41 | P09086 | |
| FYHQQFQQPPLLQQK | 766 | Q5T7B8 | |
| KQQNYQQASSFPPHE | 981 | Q86UP2 | |
| NPEVVQQFHNPDTIF | 766 | Q9UPP2 | |
| TKPLFHFNSDQANQQ | 556 | Q8IZL2 | |
| PSQNKPSLLHYTQQQ | 576 | Q8IZL2 | |
| FLKSNVQANLPPHIQ | 101 | Q8WXB1 | |
| LHQQFNKFIAPSVPQ | 1051 | Q6ZP82 | |
| SFFKIHPQVVNPVQQ | 746 | Q9H799 | |
| QKNAFVNQPTADLHP | 2556 | Q99715 | |
| PENPQNIITHNSFNS | 826 | Q9P2H0 | |
| QIQNIFVVPPNQKSH | 516 | Q9H5Z1 | |
| QFHFVLNQSPNNIPA | 151 | Q6PD62 | |
| PDFATQPQHVQNFLL | 71 | Q9Y2A9 | |
| LNPFNKQSGPRQHEQ | 76 | Q6ZN54 | |
| KQQPPNSFSQQHSET | 51 | O75208 | |
| LPQAQTDQAQSHQFP | 146 | Q9BSE4 | |
| SAPTQILAQFPKQHQ | 391 | Q7Z589 | |
| ILAQFPKQHQQSPKQ | 396 | Q7Z589 | |
| FLQENAVFHKPQPFQ | 286 | O94868 | |
| ASFQAQNEPLTQKPH | 396 | O95104 | |
| NTRKQKNGFPPNFIH | 1111 | O00411 | |
| QQQQFSSLDDKPQFP | 41 | P12694 | |
| TQAQVNQHKVAYQPP | 776 | P0C091 | |
| MPNQHFRQNPAENFS | 171 | Q9Y3Y4 | |
| EGNTFQQSQQPKPHL | 146 | Q5TD94 | |
| SQPFNPDAAQANKNH | 966 | Q8WZA2 | |
| NTNTKGHVKNFFNPP | 2181 | P12259 | |
| NHQVFSNPPKILTVQ | 501 | Q8TE76 | |
| QQHSPQQIAYSPFNL | 411 | P48436 | |
| QQSPKLQFSFLGQHP | 3986 | Q9P2P6 | |
| LQFSFLGQHPQQLQP | 3991 | Q9P2P6 | |
| SNKPQRPVFTHENIQ | 1026 | O94875 | |
| FPLQQSTFPQSHHQQ | 806 | O15516 | |
| QKPSQNFQIQAAEPT | 336 | Q02086 | |
| QLQHPVNFTSNIQPI | 171 | Q7Z5A4 | |
| KNNVKAHFQNFPNGV | 81 | Q92973 | |
| KPAFGQQHQQQPKSQ | 841 | P49750 | |
| SQHFVQTPNKPDVTN | 476 | Q96SK2 | |
| QVPAPAQSQTQFHVQ | 211 | Q15942 | |
| QHFIAQPGVQNFLSK | 666 | Q7Z2W7 | |
| GKPSPSQQVQQQSYH | 861 | P31629 | |
| QHQKVQAPEQPFDHN | 201 | Q96SR6 | |
| ILQTFPHPQSNNDQQ | 756 | Q6N021 | |
| EKANPSPVQIAHFFQ | 526 | Q8N2I2 | |
| NHKQIPYQPQNNHDS | 331 | O75386 | |
| KQAVNNQFPFSVHDN | 61 | Q5VZQ5 | |
| HFFQPTNQQFKSLPE | 506 | Q96FV9 | |
| IFTLPQQPNQKFHLS | 76 | Q96MV8 |